| Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens AM Sandri, CB Landersdorfer, J Jacob, MM Boniatti, MG Dalarosa, ... Clinical Infectious Diseases 57 (4), 524-531, 2013 | 278 | 2013 |
| Penetration of antibacterials into bone CB Landersdorfer, JB Bulitta, M Kinzig, U Holzgrabe, F Sörgel Clinical pharmacokinetics 48 (2), 89-124, 2009 | 239 | 2009 |
| Acrylamide: increased concentrations in homemade food and first evidence of its variable absorption from food, variable metabolism and placental and breast milk transfer in humans F Sörgel, R Weissenbacher, M Kinzig-Schippers, A Hofmann, M Illauer, ... Chemotherapy 48 (6), 267-274, 2002 | 219 | 2002 |
| Pharmacokinetics and pharmacodynamics of ‘old’polymyxins: what is new? PJ Bergen, CB Landersdorfer, J Zhang, M Zhao, HJ Lee, RL Nation, J Li Diagnostic microbiology and infectious disease 74 (3), 213-223, 2012 | 178 | 2012 |
| Combination therapy for carbapenem-resistant Gram-negative bacteria AP Zavascki, JB Bulitta, CB Landersdorfer Expert review of anti-infective therapy 11 (12), 1333-1353, 2013 | 155 | 2013 |
| ‘Old’antibiotics for emerging multidrug-resistant bacteria PJ Bergen, CB Landersdorfer, HJ Lee, J Li, RL Nation Current opinion in infectious diseases 25 (6), 626, 2012 | 110 | 2012 |
| Development of a new pre-and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT JB Bulitta, A Bingölbali, BS Shin, CB Landersdorfer The AAPS journal 13 (2), 201-211, 2011 | 106 | 2011 |
| Evaluation by Monte Carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers WA Krueger, J Bulitta, M Kinzig-Schippers, C Landersdorfer, U Holzgrabe, ... Antimicrobial agents and chemotherapy 49 (5), 1881-1889, 2005 | 106 | 2005 |
| Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus CB Landersdorfer, WJ Jusko Clinical pharmacokinetics 47 (7), 417-448, 2008 | 100 | 2008 |
| Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models JB Bulitta, CB Landersdorfer The AAPS journal 13 (2), 212-226, 2011 | 78 | 2011 |
| Colistin: how should it be dosed for the critically ill? CB Landersdorfer, RL Nation Seminars in respiratory and critical care medicine 36 (01), 126-135, 2015 | 62 | 2015 |
| Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance NS Ly, JB Bulitta, GG Rao, CB Landersdorfer, PN Holden, A Forrest, ... Journal of antimicrobial chemotherapy 70 (5), 1434-1442, 2015 | 58 | 2015 |
| Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis AM Sandri, CB Landersdorfer, J Jacob, MM Boniatti, MG Dalarosa, ... Journal of Antimicrobial Chemotherapy 68 (3), 674-677, 2013 | 57 | 2013 |
| Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin CB Landersdorfer, CMJ Kirkpatrick, M Kinzig-Schippers, JB Bulitta, ... Antimicrobial agents and chemotherapy 51 (9), 3290-3297, 2007 | 57 | 2007 |
| Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling JB Bulitta, NS Ly, CB Landersdorfer, NA Wanigaratne, T Velkov, R Yadav, ... Antimicrobial Agents and Chemotherapy 59 (4), 2315-2327, 2015 | 55 | 2015 |
| Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design CB Landersdorfer, NS Ly, H Xu, BT Tsuji, JB Bulitta Antimicrobial agents and chemotherapy 57 (5), 2343-2351, 2013 | 55 | 2013 |
| Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system HY Lin, CB Landersdorfer, D London, R Meng, CU Lim, C Lin, S Lin, ... PLoS Comput Biol 7 (2), e1001073, 2011 | 53 | 2011 |
| Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii R Yadav, CB Landersdorfer, RL Nation, JD Boyce, JB Bulitta Antimicrobial agents and chemotherapy 59 (4), 2286-2298, 2015 | 51 | 2015 |
| Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use PJ Bergen, ZP Bulman, S Saju, JB Bulitta, C Landersdorfer, A Forrest, J Li, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (1 …, 2015 | 50 | 2015 |
| Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis AA Agyeman, KL Chin, CB Landersdorfer, D Liew, R Ofori-Asenso Mayo Clinic Proceedings, 2020 | 47 | 2020 |
